The new prostacyclin analog treprostinilGU Zhi-chun, LIU Xiao-yan, SHEN Jie-yan, CAI Zong-ye2585-2588,2592
Comparison of drug post-marketing studies among the different agenciesZHAO Jian-zhong, XIE Song-mei, YANG Jin-bo, WANG Tao2589-2592
Appropriateness analysis for the regulation of drug post-marketing safety between the government and pharmaceutical companiesZHANG Hao, WU Zhi-ang2593-2596,2623
Rules and regulations for off-label use of drug in US from the perspective of risk regulationXU Rong, SUN Xin-xin, SHAO Ming-li2597-2601,2650
Research and development of the pediatric drugs in China:status and problem analysisGUO Zhi-gang, WU Bin, GUAN Xiao-dong, CONG Luo-luo, SHI Lu-wen2602-2606
Establishment and advance of guidance system of nonclinical evaluation for pharmaceuticals in ChinaWANG Qing-li2607-2610,2658
Effect of compound reserpine on intestinal flora in miceLI Hui-fen, CAO Yun-fei, CUI Wei-liang, ZHANG Xue-lan, TIAN Jing-zhen2611-2613,2663
Simultaneous determination of fifteen components in Shuanghuanglian powder for injection by HPLCLI Wen-chun, SUN Yong-hui, XIE Li-wen, FU Rao, LI Chang-xin, SU De-long, WANG Ying-xin2614-2618,2630
Isolation of endophytic bacteria from Acanthopanax senticosus and their antimicrobial activitiesGUO Xiao-lu, LU Bin-yu, ZHENG Chun-ying2619-2623